Recognise and support the failing RV: optimise preload, maintain systemic pressure, reduce afterload and add inotropes, and ventilate safely.
At the bedside
- 1
Confirm on echo
RV dilated (RV/LV > 1 in apical 4-chamber), TAPSE < 17 mm, septal flattening (D-shaped LV), dilated non-collapsing IVC, tricuspid regurgitation; estimate PASP.
- 2
Treat the cause
PE: reperfusion; RV infarct: revascularise, avoid nitrates; ARDS: reduce plateau pressure/driving pressure, correct hypercapnia, consider prone; arrhythmia: restore sinus rhythm (atrial kick matters).
- 3
Optimise preload
If CVP low and no congestion: cautious 250-500 mL bolus. If CVP high (> 12-15 mmHg) or congested: diuretics or ultrafiltration; volume removal often improves RV function.
- 4
Maintain systemic pressure
Noradrenaline first line to keep MAP ≥ 65 mmHg (preserves RCA perfusion). Vasopressin is an option (less pulmonary vasoconstriction).
- 5
Add inotropy
Dobutamine 2.5-10 mcg/kg/min, or milrinone/levosimendan (both reduce PVR but cause hypotension; combine with noradrenaline).
- 6
Reduce RV afterload
Correct hypoxaemia, hypercapnia and acidosis; inhaled nitric oxide or inhaled prostacyclin in specialist centres.
- 7
Ventilate carefully
Avoid intubation if possible. If needed: induce with haemodynamically stable agents and vasopressor ready; Vt 6 mL/kg, plateau < 27-30 cmH2O, lowest PEEP that maintains oxygenation, avoid hypercapnia. Consider ECMO/mechanical RV support for refractory cases.
Maintain MAP / coronary perfusion
Noradrenaline
- Dose
- 0.05-0.5 mcg/kg/min
- Preparation
- 4 mg in 50 mL = 80 mcg/mL
- Target
- MAP ≥ 65 mmHg
- Worked example
- 70 kg at 0.1 mcg/kg/min = 5.25 mL/h
Inotrope
Dobutamine
- Dose
- 2.5-10 mcg/kg/min
- Preparation
- 250 mg in 50 mL = 5,000 mcg/mL
- Worked example
- 70 kg at 5 mcg/kg/min = 4.2 mL/h
Calculators for this topic
Acute RV failure support
Step 1 of ~7
Identify and treat cause (PE, RV infarct, ARDS, arrhythmia, PH crisis)
Based on Harjola VP, Mebazaa A, Celutkiene J, et al. Educational use; follow local protocol.
Pathophysiology
The RV is a thin, compliant volume pump that tolerates volume but not pressure. Unlike the LV it is perfused in both systole and diastole, so RV coronary perfusion depends on the gradient between aortic pressure and RV pressure. Ventricular interdependence via the septum and pericardium means a dilated RV directly reduces LV filling.
Evidence
- The HFA/ESC 2016 statement summarises physiology-based management: treat cause, optimise volume, vasopressors to maintain perfusion pressure, inotropes and pulmonary vasodilators [Harjola 2016].
Controversies
- Choice between dobutamine, milrinone and levosimendan; limited RCT evidence.
- Timing of mechanical RV support or ECMO.
🇮🇳 India notes
- Rheumatic mitral stenosis with pulmonary hypertension and RV failure is still common in India, especially in pregnancy; treat AF and tachycardia aggressively.
- Inhaled nitric oxide is available in few Indian ICUs; inhaled or IV sildenafil is sometimes used as an alternative pulmonary vasodilator (specialist advice).
References
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

